• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素可减轻健康受试者餐后血糖反应:一项交叉、随机对照研究。

Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study.

机构信息

Nutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, NSW, Australia.

Riddet Institute, Massey University, Palmerston North, New Zealand.

出版信息

Sci Rep. 2018 Sep 12;8(1):13679. doi: 10.1038/s41598-018-32032-x.

DOI:10.1038/s41598-018-32032-x
PMID:30209353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6135827/
Abstract

In the current study, we aimed to evaluate the effects of a single dose of curcumin and/or fish oil on postprandial glycaemic parameters in healthy individuals. This was a randomised, placebo-controlled and crossover study. Sixteen (n = 16) volunteers were randomised to receive placebo, curcumin (180 mg) tablets, fish oil (1.2 g long chain omega-3 polyunsaturated fatty acids) capsules and curcumin + fish oil prior to a standard meal on 4 test days separated by a week. Blood glucose, serum insulin and triglycerides were measured at intervals between 0-120 min. Difference between the treatments was measured using two-way repeated measures analysis of variance and pair-wise comparisons using Wilcoxon signed-rank or paired t-test as appropriate. Postprandial glucose concentrations were significantly lower in the curcumin (60.6%, P = 0.0007) and curcumin + fishoil group (51%, P = 0.002) groups at 60 min from baseline. Compared with placebo, area under the curve (AUC) for change in blood glucose concentration was reduced by curcumin (36%, P = 0.003) and curcumin + fishoil (30%, 0.004), but not fish oil alone (p = 0.105). Both curcumin (P = 0.01) and curcumin + fishoil (P = 0.03) treatments significantly lowered postprandial insulin (AUC) by 26% in comparison with placebo. Curcumin, but not fish oil, reduces postprandial glycaemic response and insulin demand for glucose control.

摘要

在当前的研究中,我们旨在评估姜黄素和/或鱼油单次剂量对健康个体餐后血糖参数的影响。这是一项随机、安慰剂对照和交叉研究。16 名志愿者(n=16)随机分为安慰剂组、姜黄素(180mg)片组、鱼油(1.2g 长链 ω-3 多不饱和脂肪酸)胶囊组和姜黄素+鱼油组,在 4 个测试日之前,每个测试日之间间隔一周,接受标准餐。在 0-120 分钟之间的间隔测量血糖、血清胰岛素和甘油三酯。使用双向重复测量方差分析测量处理之间的差异,并使用 Wilcoxon 符号秩或配对 t 检验进行适当的两两比较。与基线相比,姜黄素(60.6%,P=0.0007)和姜黄素+鱼油组(51%,P=0.002)在 60 分钟时餐后血糖浓度显著降低。与安慰剂相比,姜黄素(36%,P=0.003)和姜黄素+鱼油(30%,P=0.004)降低了血糖浓度变化的曲线下面积(AUC),但鱼油单独(p=0.105)没有。与安慰剂相比,姜黄素(P=0.01)和姜黄素+鱼油(P=0.03)治疗均显著降低了餐后胰岛素(AUC)的 26%。姜黄素而不是鱼油,可降低餐后血糖反应和胰岛素对葡萄糖控制的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/8465616c15b5/41598_2018_32032_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/8273146e5009/41598_2018_32032_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/3187a13d696d/41598_2018_32032_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/8465616c15b5/41598_2018_32032_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/8273146e5009/41598_2018_32032_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/3187a13d696d/41598_2018_32032_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d4/6135827/8465616c15b5/41598_2018_32032_Fig3_HTML.jpg

相似文献

1
Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study.姜黄素可减轻健康受试者餐后血糖反应:一项交叉、随机对照研究。
Sci Rep. 2018 Sep 12;8(1):13679. doi: 10.1038/s41598-018-32032-x.
2
Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study.进食富含中链饱和和/或长链ω-3 多不饱和脂肪酸的膳食后餐后血脂。一项随机交叉研究。
Clin Nutr. 2021 Feb;40(2):420-427. doi: 10.1016/j.clnu.2020.06.027. Epub 2020 Jul 1.
3
Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.鱼油对非胰岛素依赖型糖尿病伴高甘油三酯血症患者胰岛素抵抗和血浆脂蛋白的长期影响。
Diabetes Care. 1996 Nov;19(11):1207-13. doi: 10.2337/diacare.19.11.1207.
4
Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.口服胰岛素产品(HIM2)对2型糖尿病患者餐后血糖的控制
Diabetes Care. 2003 Feb;26(2):421-6. doi: 10.2337/diacare.26.2.421.
5
Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial.姜黄素和/或欧米伽-3 多不饱和脂肪酸补充剂可降低 2 型糖尿病高危人群的胰岛素抵抗和血脂:一项随机对照试验。
Lipids Health Dis. 2019 Jan 26;18(1):31. doi: 10.1186/s12944-019-0967-x.
6
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.在2型糖尿病患者中,与赖脯胰岛素联合使用时,普兰林肽可减少餐后血糖波动:一项剂量-给药时间研究。
Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60. doi: 10.1002/dmrr.419.
7
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.在1型糖尿病患者中,与常规胰岛素或赖脯胰岛素联用时,普兰林肽可降低餐后血糖波动:一项剂量-给药时间研究。
Diabetes Care. 2003 Nov;26(11):3074-9. doi: 10.2337/diacare.26.11.3074.
8
Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.艾塞那肽:注射时间对2型糖尿病患者餐后血糖的影响
Diabet Med. 2006 Mar;23(3):240-5. doi: 10.1111/j.1464-5491.2006.01800.x.
9
Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.1型糖尿病患者使用门冬胰岛素30进行餐后血糖控制。
Metabolism. 2002 Jul;51(7):896-900. doi: 10.1053/meta.2002.33358.
10
Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.皮下注射胰高血糖素样肽-1可改善早期2型糖尿病患者3周内的餐后血糖控制。
Clin Sci (Lond). 1998 Sep;95(3):325-9.

引用本文的文献

1
A market and risk assessment of 125 turmeric supplements available in Australia, Germany, India, UK, and USA.对澳大利亚、德国、印度、英国和美国市场上125种姜黄补充剂的市场与风险评估。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 7. doi: 10.1007/s00210-025-04392-5.
2
Evaluation of the anti-diabetic and anti-inflammatory potentials of curcumin nanoparticle in diabetic rat induced by streptozotocin.姜黄素纳米颗粒对链脲佐菌素诱导的糖尿病大鼠的抗糖尿病和抗炎潜力评估。
Open Vet J. 2024 Dec;14(12):3375-3387. doi: 10.5455/OVJ.2024.v14.i12.22. Epub 2024 Dec 31.
3
Silver Nanoparticles Decorated with Curcumin Enhance the Efficacy of Metformin in Diabetic Rats via Suppression of Hepatotoxicity.

本文引用的文献

1
Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models.姜黄素对2型糖尿病大鼠模型血清中糖脂代谢、游离脂肪酸和肿瘤坏死因子-α的影响。
Saudi J Biol Sci. 2017 Dec;24(8):1776-1780. doi: 10.1016/j.sjbs.2017.11.011. Epub 2017 Nov 9.
2
Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure.姜黄素激活长期服用氯氮平的大鼠的AMPK通路并调节脂质代谢。
Front Neurosci. 2017 Oct 4;11:558. doi: 10.3389/fnins.2017.00558. eCollection 2017.
3
Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials.
姜黄素修饰的银纳米颗粒通过抑制肝毒性增强二甲双胍对糖尿病大鼠的疗效。
Toxics. 2023 Oct 18;11(10):867. doi: 10.3390/toxics11100867.
4
The Effect of Omega-3 Fatty Acids on Insulin Resistance.ω-3脂肪酸对胰岛素抵抗的影响。
Life (Basel). 2023 Jun 5;13(6):1322. doi: 10.3390/life13061322.
5
Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises.姜黄素治疗多囊卵巢综合征的潜力:药理学见解与治疗前景
Heliyon. 2023 Jun 2;9(6):e16957. doi: 10.1016/j.heliyon.2023.e16957. eCollection 2023 Jun.
6
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.姜黄和姜黄素在慢性病防治中的作用:来自临床试验的经验教训。
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14.
7
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?提高生物利用度的姜黄素制剂:我们目前从临床试验中学到了什么?
ACS Omega. 2023 Mar 13;8(12):10713-10746. doi: 10.1021/acsomega.2c07326. eCollection 2023 Mar 28.
8
Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials.姜黄素补充剂与人类疾病:临床试验的范围综述。
Int J Mol Sci. 2023 Feb 24;24(5):4476. doi: 10.3390/ijms24054476.
9
Bioactive Yoghurt Containing Curcumin and Chlorogenic Acid Reduces Inflammation in Postmenopausal Women.含姜黄素和绿原酸的活性酸奶可减轻绝经后妇女的炎症。
Nutrients. 2022 Nov 2;14(21):4619. doi: 10.3390/nu14214619.
10
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?姜黄素——具有多种效应的营养保健品?哪些心脏代谢相关受试者可能受益最大?
Front Nutr. 2022 May 17;9:865497. doi: 10.3389/fnut.2022.865497. eCollection 2022.
姜黄素或联合姜黄素类在降低血糖异常个体的空腹血糖浓度方面有效:系统评价和随机对照试验的荟萃分析。
Pharmacol Res. 2018 Feb;128:137-144. doi: 10.1016/j.phrs.2017.09.010. Epub 2017 Sep 18.
4
Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis.补充鱼油与胰岛素敏感性:一项系统评价与荟萃分析。
Lipids Health Dis. 2017 Jul 3;16(1):131. doi: 10.1186/s12944-017-0528-0.
5
Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion.姜黄素通过刺激胰高血糖素样肽-1分泌来改善葡萄糖耐量。
Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600471. Epub 2016 Dec 19.
6
Fatty acids stimulate insulin secretion from human pancreatic islets at fasting glucose concentrations via mitochondria-dependent and -independent mechanisms.在空腹血糖浓度下,脂肪酸通过线粒体依赖和非依赖机制刺激人胰岛分泌胰岛素。
Nutr Metab (Lond). 2016 Aug 30;13(1):59. doi: 10.1186/s12986-016-0119-5. eCollection 2016.
7
Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals.高生物利用度的胶束姜黄素类物质在血液中蓄积,安全且不会降低中度高脂血症个体的血脂和炎症标志物水平。
Mol Nutr Food Res. 2016 Jul;60(7):1555-63. doi: 10.1002/mnfr.201501034. Epub 2016 May 23.
8
Oral delivery of liposomes.脂质体的口服给药。
Ther Deliv. 2015;6(11):1239-41. doi: 10.4155/tde.15.69. Epub 2015 Nov 19.
9
Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.通过计算机分子对接筛选天然化合物中的α-葡萄糖苷酶和α-淀粉酶抑制剂。
Biofactors. 2015 Jul-Aug;41(4):242-51. doi: 10.1002/biof.1219. Epub 2015 Jul 7.
10
Efficacy of Turmeric as Adjuvant Therapy in Type 2 Diabetic Patients.姜黄作为2型糖尿病患者辅助治疗的疗效
Indian J Clin Biochem. 2015 Apr;30(2):180-6. doi: 10.1007/s12291-014-0436-2. Epub 2014 May 8.